Satoh H - Search Results

1

Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study.

Maezawa Y, Taguchi M, Kawakami T, Inui T, Okauchi S, Numata T, Shiozawa T, Miyazaki K, Nakamura R, Iguchi K, Endo T, Sakamoto T, Satoh H, Hizawa N. Maezawa Y, et al. Among authors: satoh h. Anticancer Res. 2024 Apr;44(4):1751-1757. doi: 10.21873/anticanres.16974. Anticancer Res. 2024. PMID: 38537995

2

Long-term survivors after chemotherapy in advanced non-small cell lung cancer.

Satoh H, Ishikawa H, Ohara G, Kagohashi K, Kurishima K, Ohtsuka M, Hizawa N. Satoh H, et al. Anticancer Res. 2007 Nov-Dec;27(6C):4457-60. Anticancer Res. 2007. PMID: 18214060 Free article.

3

Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.

Miyazaki K, Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi K, Ohara G, Hizawa N. Miyazaki K, et al. Among authors: satoh h. Anticancer Res. 2009 Jul;29(7):2671-4. Anticancer Res. 2009. PMID: 19596944 Free article.

4

Interstitial lung disease in patients with small cell lung cancer.

Miyazaki K, Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi K, Hizawa N. Miyazaki K, et al. Among authors: satoh h. Med Oncol. 2010 Sep;27(3):763-7. doi: 10.1007/s12032-009-9283-z. Epub 2009 Aug 6. Med Oncol. 2010. PMID: 19657749

5

Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients.

Nakamura R, Inage Y, Tobita R, Mori K, Numata T, Yanai H, Endo T, Ohtani H, Satoh H, Yuzawa K, Koizumi M, Ueki H. Nakamura R, et al. Among authors: satoh h. J Thorac Oncol. 2014 Sep;9(9):1340-4. doi: 10.1097/JTO.0000000000000022. J Thorac Oncol. 2014. PMID: 24481317 Free article.

6

Characteristics of clinical N0 metastatic non-small cell lung cancer.

Tamura T, Kurishima K, Watanabe H, Shiozawa T, Nakazawa K, Ishikawa H, Satoh H, Hizawa N. Tamura T, et al. Among authors: satoh h. Lung Cancer. 2015 Jul;89(1):71-5. doi: 10.1016/j.lungcan.2015.04.002. Epub 2015 Apr 13. Lung Cancer. 2015. PMID: 25913230

7

Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study.

Kaburagi T, Kiyoshima M, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Saito K, Inagaki M, Hizawa N, Sato Y, Ishikawa H, Sakai M, Kamiyama K, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Yamashita T, Nomura A, Yoshida S. Kaburagi T, et al. Among authors: satoh h. Anticancer Res. 2018 May;38(5):3145-3150. doi: 10.21873/anticanres.12577. Anticancer Res. 2018. PMID: 29715155

8

Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M Mutation.

Miyazaki K, Tamura T, Kaburagi T, Saito K, Inagaki M, Yamashita T, Ichimura H, Nawa T, Endo T, Hayashihara K, Kimura M, Kurishima K, Nakamura H, Furukawa K, Kikuchi N, Satoh H, Hizawa N. Miyazaki K, et al. Among authors: satoh h. Anticancer Res. 2018 Sep;38(9):5409-5415. doi: 10.21873/anticanres.12871. Anticancer Res. 2018. PMID: 30194196

9

Factors Associated With Distant Metastasis in EGFR-mutated Non-small Cell Lung Cancer Patients: Logistic Analysis.

Watanabe H, Okauchi S, Miyazaki K, Satoh H, Hizawa N. Watanabe H, et al. Among authors: satoh h. In Vivo. 2019 Jul-Aug;33(4):1369-1372. doi: 10.21873/invivo.11613. In Vivo. 2019. PMID: 31280232 Free PMC article.

10

Factors associated with recurrent leptomeningeal metastases in patients with EGFR-mutated non-small-cell lung cancer.

Watanabe H, Okauchi S, Miyazaki K, Satoh H, Hizawa N. Watanabe H, et al. Among authors: satoh h. Pol Arch Intern Med. 2019 Nov 29;129(11):836-838. doi: 10.20452/pamw.14948. Epub 2019 Aug 28. Pol Arch Intern Med. 2019. PMID: 31456585 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,723 results

Search Page